Reimbursement Strategies for Breast Cancer
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Reimbursement for breast cancer?
The research suggests that new reimbursement strategies, like episode-based payments and the Oncology Medical Home program, can improve patient outcomes by aligning financial incentives with better care practices and reducing unnecessary costs. These strategies have shown promise in enhancing care quality and reducing avoidable hospital visits, which could indirectly support better outcomes for breast cancer patients.12345
How does the treatment in the 'Reimbursement Strategies for Breast Cancer' trial differ from other breast cancer treatments?
What is the purpose of this trial?
The goal of this clinical trial is to identify the recommended financial reimbursement amount for women with breast cancer enrolled in a clinical trial. The main questions it aims to answer are:1. What is the recommended financial reimbursement amount in trial-enrolled women with breast cancer experiencing financial toxicity?2. What do patients think about receiving a reimbursement for trial-incurred expenses?Participants will receive a monthly reimbursement to compensate for their trial-incurred expenses in cohorts, which will de-escalate for the next participant cohort if patients find the reimbursement dose suitable (negative financial toxicity screen, reimbursement dose deemed acceptable/appropriate). Researchers will also use qualitative interviews to explore patient perceptions of the trial reimbursements.
Research Team
Courtney Williams, DrPH
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for women with breast cancer who are already part of the I-SPY TRIAL 2 at UAB Medical Oncology Clinic. It's not open to men, non-English speakers, or female patients not enrolled in I-SPY TRIAL 2.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a monthly reimbursement to offset trial-related expenses
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Reimbursement
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor